Crossmark

Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC

Crossref DOI link: https://doi.org/10.1038/onc.2015.499

Published Online: 2016-01-18

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Taylor, M A

Wappett, M

Delpuech, O

Brown, H

Chresta, C M
License Information

Text and Data Mining valid from 2016-01-18
More Information

Article History

Received: 4 June 2015

Revised: 16 November 2015

Accepted: 20 November 2015

First Online: 18 January 2016

Competing interests

: All authors are employees of AstraZeneca.

Document is current

Any future updates will be listed below